Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2000

View Archived Issues

Medeva's Hepagene study shows promising results as treatment of chronic HBV

Periodontix raises funding for further development of HistaWash

Pharmacia & Upjohn and Geron extend telomerase collaboration

Therapeutic protein discovery partnership formed by Bayer and Incyte

Afferon steps up development of RTX for treatment of urge incontinence

Arena granted SBIR award for atypical antipsychotics

Neurocrine Biosciences updates clinical progress with IL-4 fusion toxin

SmithKline Beecham signs CpG DNA immune stimulant agreement

FDA approves two-dose regimen of Merck & Co.'s Recombivax HB for adolescent use

Positive results for memantine in phase IIb trial for treatment of neuropathy

Human Genome Sciences initiates phase II clinical trial of repifermin for mucositis

Synthesis, use of series of PDE4 inhibitors reported by Merck

Compounds active at human 5-HT1A receptors designed at AHP

Selective inhibitors of alpha4 integrin binding for inflammatory, immune disorders

Pfizer patents new series of COX-2 inhibitors with sulfonybenzene structure

Melanocortin receptor agonists and their use disclosed by Merck

Schering's new agents for eating disorders and diabetes presented in international patent

Novel amidino derivatives and their use as NOS inhibitors reported by Searle

Wide series of cell adhesion inhibitors in the Merck pipeline

German colorectal cancer patients have new treatment option: Sanofi-Synthelabo's Eloxatin

Enhancement of both upper and lower GI motility associated with selective 5-HT4 agonist

Ramipril and aminoguanidine both prevent albuminuria and normalize PKC in diabetic rats

Lipitor recommended for approval in Japan

RPR-120844: pharmacodynamic and antithrombotic profile of a new factor Xa inhibitor

Barr and DuPont to establish collaborative agreement

NAALADase inhibition as an effective and safe therapeutic strategy for stroke

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...